Jeff Kindler, a lawyer tapped as a fresh face to lead drugmaker Pfizer out of its dodrums, is out, after just a little over four years as chairman and chief excutive, reports NPR's health blog. Kindler's executive bio already has been erased from Pfizer's website. Ian C. Read, 57, head of the company's global biopharmaceuticals operations, is in.
Shareholders of two companies set to be acquired are suing over the offers, alleging that the companies breached their fiduciary duties in agreeing to the buyouts. Investors in AGA Medical Holdings Inc. (NASDAQ:AGAM) sued in the Delaware Chancery Court over St. Jude Medical Inc.’s (NYSE:STJ) $1.3 billion offer for AGA, alleging that “the proposed transaction […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
General Electric Co.’s (NYSE:GE) healthcare unit has agreed to acquire molecular diagnostics firm Clarient Inc. (NASDAQ:CLRT) for about $587 million in cash. GE is growing its disease-diagnosis business and said the cancer profiling market will increase from its 2009 $15 billion value to $47 billion by 2015. The deal stipulates a $20 price per preferred […]